Physiological concentration of protocatechuic acid directly protects vascular endothelial function against...

Area of Science:

• * Biochemistry and Molecular Biology
• * Cardiovascular Research
• * Nutritional Science

Background:

• * Cardiovascular diseases (CVDs) are the leading cause of mortality in type 2 diabetes patients.
• * Current diabetes medications primarily focus on glycemic control and do not sufficiently reduce CVD mortality.
• * Protocatechuic acid (PCA), a phenolic acid found in plant-based foods, exhibits known antioxidant properties.

Purpose of the Study:

• * To investigate the direct effects of PCA on endothelial function in the context of diabetes.
• * To explore PCA's anti-inflammatory mechanisms specifically within endothelial cells.
• * To determine if PCA can ameliorate diabetes-induced endothelial dysfunction.

Main Methods:

• * Utilized an IL-1β-induced inflammation model in endothelial cells and db/db mouse aortas.
• * Assessed endothelium-dependent relaxation and reactive oxygen species (ROS) production.
• * Measured the expression of pro-inflammatory cytokines (MCP1, VCAM1, ICAM1) and the phosphorylation status of Akt and eNOS.

Main Results:

• * PCA significantly improved endothelium-dependent relaxation and reduced ROS overproduction in diabetic mouse aortas.
• * PCA demonstrated potent anti-inflammatory effects by suppressing key cytokines (MCP1, VCAM1, ICAM1) in an IL-1β-induced endothelial cell model.
• * PCA increased the phosphorylation of Akt and eNOS, crucial for endothelial function, and this effect was dependent on Akt phosphorylation.

Conclusions:

• * PCA protects vascular endothelial function against inflammation via the Akt/eNOS pathway.
• * The findings suggest PCA has direct beneficial effects on endothelial cells, complementing its systemic vascular benefits.
• * Daily intake of PCA may be encouraged for individuals with type 2 diabetes to support cardiovascular health.